Albemarle Corporation
NYSE:ALBChemicals - Specialty
-$6.21 today
- Market cap
- $10.13B
- Beta
- 1.31
- P/E (TTM)
- -81.1
- EPS (TTM)
- -$1.98
- Dividend yield
- 1.01%
Volume 2.16M
Average 2.29M
ALB Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Albemarle CorporationNYSE: ALB
Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026
Change in working capital declines year over year
Q2 FY2026 change in working capital of $91.31M fell 62.5% year over year, ahead of the -65.2% change in trailing-twelve-month change in working capital.
Context
- Change in working capital amounted to 13.5% of revenue in FY2025, down 0.2 pp from a year earlier.
- Change in working capital increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -62.5% holds above the trailing-twelve-month pace of -65.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- 694.38M USD
- Year-over-year change
- -5.8%
- 4-year CAGR
- +57.9%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 694.38M | -5.8% |
| FY2024 | 2024-12-31 | 736.87M | +173.2% |
| FY2023 | 2023-12-31 | (1.01B) | +28.8% |
| FY2022 | 2022-12-31 | (1.41B) | -1366.3% |
| FY2021 | 2021-12-31 | 111.72M | — |
Change in Working Capital vs competitors
How ALB compares with its peers on the latest reported figures
- ALB's LTM Jun 2026 change in working capital of $419.98M is the largest of the 4 companies compared; the peer median is $1.42M.
- Its year-over-year change of -65.2% is the highest of 2, against a peer median of -73.1%.
- Change in working capital amounts to 7.1% of revenue for ALB, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $419.98M | -65.2% | — | 7.1% | |
| LTM Mar 2026 | $3.05M | — | — | — | |
| LTM Mar 2026 | $1.42M | -73.1% | -12.1% | — | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALB) | $1.42M | -73.1% | -12.1% | 0.0% | |
Competitors are the stored peer set for ALB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 199.94M | 2.82B | 1.67B | (1.14B) | (465.21M) |
| Depreciation & Amortization | 254M | 300.84M | 429.94M | 588.64M | 658.68M |
| Deferred Income Tax | (38.5M) | 93.34M | 100.88M | (230.41M) | 81.17M |
| Stock-Based Compensation | 20.12M | 30.47M | 36.55M | 32.14M | 40.27M |
| Change in Working Capital | 111.72M | (1.41B) | (1.01B) | 736.87M | 694.38M |
| Accounts Receivables | (49.3M) | (786.12M) | (350.66M) | 555.22M | 47.32M |
| Inventory | (127.4M) | (1.61B) | (353.56M) | 1.06B | 212.35M |
| Accounts Payables | 143.94M | 1.29B | (283.41M) | (862.24M) | 128.15M |
| Other Working Capital | 144.48M | (306.01M) | (19.63M) | (11.15M) | 306.56M |
| Other Non-Cash Items | (203.03M) | 82.77M | 95.93M | 696.11M | 272.98M |
| Operating Cash Flow | 344.26M | 1.91B | 1.33B | 687.88M | 1.28B |
| Capital Expenditures | (953.67M) | (1.26B) | (2.15B) | (1.68B) | (589.8M) |
| Acquisitions (Net) | 283.3M | (162.95M) | (427.43M) | (270K) | (239K) |
| Purchases of Investments | (6.49M) | (706K) | (204.45M) | (15.6M) | 0 |
| Sales of Investments | 3.77M | 1.94M | 221.85M | 82.52M | 411.22M |
| Other Investing Activities | 6.49M | 706K | 0 | 29.1M | 32.81M |
| Investing Cash Flow | (666.59M) | (1.42B) | (2.56B) | (1.58B) | (146.01M) |
| Debt Repayment | (1.11B) | 867.55M | 944.2M | (631.83M) | (454.67M) |
| Common Stock Issued | 1.45B | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (177.85M) | (184.43M) | (187.19M) | (311.28M) | (357.28M) |
| Other Financing Activities | (112.99M) | (71.24M) | (133.1M) | (51.91M) | (22.24M) |
| Financing Cash Flow | 50.21M | 611.89M | 623.91M | 1.24B | (834.19M) |
| Effect of Forex Changes | (35.33M) | (37.22M) | 4.84M | (42.51M) | 123.7M |
| Net Change in Cash | (307.45M) | 1.06B | (609.24M) | 302.33M | 425.77M |
| Free Cash Flow | (609.41M) | 646.2M | (827.96M) | (992.65M) | 692.47M |
Albemarle Corporation
NYSE:ALB
Intrinsic Alpha fair value
Locked
Current Price
$85.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.